Investor Relations & Fundraising
.webp)
.webp)
.webp)
.webp)
WHAT WE HELP WITH
We’re a pitch deck and investor relations agency for biotech, medtech, and deep tech companies. We build investor narratives, pitch decks, and outreach programs for companies preparing to raise, plus ongoing investor communications for those managing existing shareholders, from seed to exit. All of it backed by real experience on both sides of the funding table.
Plenty of agencies treat investor relations as a PR deliverable. We treat it as a core commercial function. The same team that built your brand, your pipeline, and your AI operations turns that work into a story investors believe.
SIGNS IT'S TIME
Fundraising punishes a story that isn't tight. A few signs to fix first:
01
Three team members pitch the company three different ways.
02
Every investor meeting raises the same objection you thought the deck already answered.
03
You can explain the science, yet the business case behind it stays fuzzy.
04
You have a target list, but no warm introduction to the rooms that matter.
WHO IT'S FOR
What you need depends on where you are in the funding journey:
Shape a first narrative and deck that make a young company look fundable, not just early.
.webp)
Sharpen the story and materials to survive diligence and close a competitive round.
.webp)
Run ongoing investor relations and communicate cleanly through an acquisition or exit.
Investors decide fast, so your materials have to survive the first look: pitch decks, executive summaries, and data rooms that present your company clearly, credibly, and on your terms. Every slide answers the question an investor is already asking.
Investor Pitch Deck
Executive Summary & One-Pager
Data Room Preparation
Investor Presentation for Roadshows
Before the deck comes the story. We shape the narrative investors respond to, grounded in how they evaluate companies at each stage, from seed rounds to growth capital to M&A. Get the narrative right and every later document falls into place.
Fundraising Narrative Development
Investor Positioning & Messaging
Pre-Raise Brand & Web Readiness
The right story needs the right audience. We identify the investors who fit your stage and sector, open doors through warm introductions, and run outreach that gets you into real conversations. In fundraising, a targeted list beats a broad one every time.
Investor Targeting & Mapping
Warm Investor Introductions
Investor Outreach Program
Family Office Access Program
1
We shape the story investors respond to, built on how they evaluate your stage and sector.
2
We turn it into a pitch deck, executive summary, and data room that hold up under diligence.
3
We map the right investors and open doors through warm introductions.
4
After the round, we keep investors informed with updates, reports, and board materials.
WHY MARKENY
Our team has advised fundraising platforms and invested as angels in science and technology companies. We know what investors look for, and how to tell a story that speaks to their priorities.
We have deep relationships across life sciences VCs, family offices, and strategic investors in science and technology. When the timing is right, we help you get into rooms that are otherwise hard to reach.
We write for principals and investment committees weighing science and technology opportunities. We know how to translate complex science into a commercial narrative that holds up under real scrutiny.
Because we also build your brand, pipeline, and AI operations, your investor materials say the same thing your website, your sales team, and your metrics already do. Investors notice when a story holds together across every touchpoint, and that consistency is what turns polite interest into conviction.
We've supported raises across biotech, medtech, life sciences, deep tech, and SaaS, so we know how each sector's investors weigh risk and reward.
.webp)
WHAT OUR CLIENTS SAY
WHAT OUR CLIENTS SAY
F.A.Q.
A strong investor pitch deck for a science and technology company starts with the narrative: a clear, commercially grounded story that connects the technology to the market opportunity. It covers the problem, the solution and its edge, the market size, the team's credibility, key milestones, and a specific ask. In science and technology, de-risking the science and proving the business case carry more weight than hockey-stick projections.
Science and technology companies should start building the investor narrative 3 to 6 months before going to market. A compelling deck and clean materials take months to get right, and companies that arrive with a fully developed story consistently outperform those that build reactively. The raise itself then runs around 12 weeks from first meeting to close.
Investors weigh a clear market opportunity, a defensible technology or scientific position, a credible team, and a realistic path to commercial or clinical milestones. Confident, plain communication of your value and differentiation matters as much as the underlying science.
Both. A deck alone rarely closes a round. We also build target investor lists, warm outreach, and the positioning to get in front of the right people, and we've supported clients from early narrative work through to close, including US market entry and business development alongside the raise.
A successful fundraise typically takes around 12 to 13 weeks from first meeting to close, close to twice as fast as processes that stall. Targeted outreach to the right 20 to 30 investors, paired with a sharp narrative, consistently outperforms a broad approach.
Most IR and PR firms deliver investor communications in isolation: quarterly updates, press releases, a refreshed deck. Our investor readiness is grounded in the brand, pipeline, and AI work we've already done with you. The investor narrative comes from the same positioning your buyers see, backed by the same demand program showing traction. You get one coherent story across every audience, instead of a polished deck that doesn't match the website.
.webp)
Tell us where you want to grow and we will show you how Markeny gets you there.
